Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Manumycin polyketides act as molecular glues between UBR7 and P53

Isobe, Yosuke and Okumura, Mikiko and McGregor, Lynn and Brittain, Scott and Jones, Michael and Liang, Xiaoyou and White, Ross and Forrester, William and McKenna, Jeffrey and Tallarico, John and Schirle, Markus and Maimone, Thomas and Nomura, Daniel (2020) Manumycin polyketides act as molecular glues between UBR7 and P53. Nature chemical biology. ISSN 1552-4469; 1552-4450

Abstract

Molecular glues are an intriguing therapeutic modality that harness small molecules to induce interactions between proteins that typically do not interact. However, such molecules are rare and have been discovered fortuitously, thus limiting their potential as a general strategy for therapeutic intervention. We postulated that natural products bearing one or more electrophilic sites may be an unexplored source of new molecular glues, potentially acting through multicovalent attachment. Using chemoproteomic platforms, we show that members of the manumycin family of polyketides, which bear multiple potentially reactive sites, target C374 of the putative E3 ligase UBR7 in breast cancer cells, and engage in molecular glue interactions with the neosubstrate tumor-suppressor TP53, leading to p53 transcriptional activation and cell death. Our results reveal an anticancer mechanism of this natural product family, and highlight the potential for combining chemoproteomics and multicovalent natural products for the discovery of new molecular glues

Item Type: Article
Keywords: manumycin, asukamycin, chemoproteomics, activity-based protein profiling, natural products, covalent ligands, undruggable, protein-protein interaction (PPI)
Date Deposited: 15 Jul 2020 00:45
Last Modified: 15 Jul 2020 00:45
URI: https://oak.novartis.com/id/eprint/42341

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.